Vor Biopharma Inc. Common Stock (VOR)
Smart-money score is on the high side, with score for how it compares with the broader market is on the low side.
VOR scores higher than 71% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, Vor Biopharma Inc. Common Stock (VOR) scores 52 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.96× 30-day average
- 52-week range
- 6.50 – 33.50
- Market cap
- $1.15B
- Earnings date
- 11 Nov 2026
- Volume
- 1,102,365
- Avg. volume (30d)
- 1,148,611
- Open
- 18.99
- Previous close
- 19.13
- Day's range (regular session)
- 18.85 – 20.27
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 1.74
- P/E (TTM)
- 2.03
- EPS (TTM)
- -43.00
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for VOR
- 4 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for VOR. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about VOR right now
Vor Biopharma Inc. Common Stock (VOR) currently scores 52/100 on the Market Census six-factor composite, at the Average score level. VOR is +4.03% on the day and +6.47% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in VOR's data roughly balance out right now. VOR's strongest factor is insider trades at 74/100 — a strong read on insider buying and selling. Insider filings currently lean toward buying on this name — a plain read of public filings, not a signal to follow. The weakest factor is strength vs the market at 31/100 — below average next to the wider market.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See VOR in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent VOR news
Latest headlines that name Vor Biopharma, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Yahoo
- Durable MG Responses From Telitacicept Could Be A Game Changer For Vor Biopharma (VOR)Yahoo
- Vor Bio Announces Data Phase 3 Trial Of Telitacicept By Its RemeGen Partner Demonstrates Over 95% Participants Achieved At Least 5-Point MG-ADL Improvement Over 48 WeeksBenzinga
- Vor Biopharma: A Funded Replication Story With Franchise PotentialSeekingAlpha
- Vor Biopharma Inc. (VOR) Presents at Citigroup's Biopharma Back to School Summit 2026 TranscriptSeekingAlpha
We hide 2 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to VOR’s 52, all within 1 point.
Sorted by closeness to VOR’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.